News About: Pharm. Industry
Pharmaceutical manufacturing industry is suffering from the operation of the new mechanism for drug price cut
On Mar 19, according to the pharmaceutical manufacturing industry, they are suffering from the operation of the new mechanism for drug price cut, followed by the existing regulatory policies.
First of all, the indust...
In hepatitis B drug market, 'Viread (Tenofovir)' is showing an upward tendency
In hepatitis B drug market, 'Viread (Tenofovir)' is showing an upward tendency.
Its prescription cost exceeded already 10 billion won this year, and is increasing market share.
According to data from Ubist, it turne...
Pharmaceutical wholesale industry requested realization of distribution margin to GlaxoSmithKline
Pharmaceutical wholesale industry announced that they will demand distribution margin including financial cost to GlaxoSmithKline, and they even plan to take group action.
When wholesaler companies make a deal with p...
It was analyzed that pharmaceutical company’s debt ratio was 52.1%
Debt ratio of domestic pharmaceutical companies declined slightly last year.
According to the result of '2013 present condition of Debpt ratio' which Medipana News sum up based on 51 listed pharmaceutical companies, ...
Daewoong announced that L pharmacist should explain about Ursa situation directly
Daewoong wants to resolve an issue with L pharmacist who has sparked controversy about Ursa, but L pharmacist seems to avoid the situation. So the situation about Ursa is extending over a long period of time.
Accordi...
Revlimid for treating multiple myeloma, get applied to medical insurance benefit
People are paying attention to the effect of Revlimid, to which Ministry of Health and Welfare applied Risk-sharing contract. Celgene expects to establish a new treatment mechanism for multiple myeloma, and expand its...
The production scale of bio-industry in 2012 exceeded 7 trillion won
It turned out that the scale of domestic biotechnology industry continues to increase.
According to the result of 'Research on the actual condition of domestic bio-industry (2013.9.10-2014.2.21)' conducted by Minist...
In domestic companies, sales of products from multinational pharmaceutical companies accounted for more than 30% of total sales
Domestic pharmaceutical companies are selling the products of multinational pharmaceutical companies to overcome decrease in sales due to overall drug price cut carried out in April 2012. Now in domestic companies, sa...
40 listed pharmaceutical companies conduct cash dividend with a total of more than 100 billion won
About 40 listed pharmaceutical companies conduct cash dividend with a total of more than 100 billion won.
Yakup.com analyzed disclosure status of KOSPI and KOSDAQ-listed pharmaceutical company, and it turned out that...
Bayer Korea withdrew the policy of reducing distribution margin
According to the pharmaceutical wholesale industry, On Mar 13, CEO Niels Hessmann from Bayer Korea visited Korea Pharmaceutical Wholesalers Association and decided to raise distribution margin.
In the meeting, it was...
